Skip to main content
INKON Life Technology Co., Ltd. logo

INKON Life Technology Co., Ltd. — Investor Relations & Filings

Ticker · 300143 ISIN · CNE100000XF6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,851 across all filing types
Latest filing 2021-04-28 Report Publication Anno…
Country CN China
Listing Shenzhen Stock Exchange 300143

About INKON Life Technology Co., Ltd.

https://www.inkonlife.com

INKON Life Technology Co., Ltd. specializes in the development and manufacture of advanced medical equipment and digital healthcare solutions. The company focuses on two primary sectors: radiotherapy equipment and digital medical services. Its core product portfolio includes high-precision radiotherapy systems, such as the Gamma Knife, and medical infusion systems. INKON Life leverages Internet of Things (IoT) technology to provide integrated digital hospital solutions, aiming to improve clinical efficiency and patient outcomes. The company serves oncology centers and medical institutions by providing comprehensive cancer treatment solutions and smart healthcare management platforms. By combining medical engineering with digital innovation, INKON Life focuses on the modernization of radiotherapy and the digital transformation of healthcare delivery.

Recent filings

Filing Released Lang Actions
一季报披露提示性公告
Report Publication Announcement Classification · 95% confidence The document is a short announcement (402 characters) regarding the disclosure of the company's 2021 first quarter report. It states that the full quarterly report will be published on a specific date and provides a link to the official disclosure website. There is no actual financial data or detailed report content included in this document. According to the 'MENU VS MEAL' rule, this is an announcement about the report publication, not the report itself. Therefore, the correct classification is Report Publication Announcement (RPA).
2021-04-28 Chinese
关于2020年年度报告全文的更正公告
Regulatory Filings Classification · 95% confidence The document is a correction announcement regarding the company's 2020 Annual Report. It references the full 2020 Annual Report and details corrections to specific sections such as remuneration of directors and use of raised funds. The document explicitly states it is a correction to the '2020 年年度报告全文' (2020 Annual Report full text). The length is 8186 characters, which is substantial, but the content is focused on corrections rather than the full report itself. The document does not contain the full financial statements or comprehensive analysis but rather corrections to previously disclosed data. According to the 'Menu vs Meal' rule, a document that announces corrections or changes to a report but does not contain the full report itself should be classified as a Regulatory Filing (RNS). Therefore, this document is best classified as a Regulatory Filing (RNS) with high confidence.
2021-04-28 Chinese
2020年年度报告（已取消）
Annual Report Classification · 100% confidence The document is titled "盈康生命科技股份有限公司 2020 年年度报告全文" which translates to "INKON Life Technology Co., Ltd. 2020 Annual Report Full Text." It contains detailed sections typical of an annual report, including company overview, financial data for the year 2020, business overview, management discussion, and financial statements. The document references the fiscal year 2020 (January 1, 2020 to December 31, 2020) and includes audited financial data, management statements, and comprehensive business analysis. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement or summary. There is no indication that this is a call transcript, proxy statement, or other filing type. Therefore, this document fits the definition of an Annual Report (10-K). FY 2020
2021-04-28 Chinese
2020年年度报告（已取消）
Annual Report Classification · 100% confidence The document is titled "盈康生命科技股份有限公司 2020 年年度报告全文" which translates to "INKON Life Technology Co., Ltd. 2020 Annual Report Full Text." It contains detailed sections including company overview, financial data, business summary, management discussion, and financial statements. The document length is 15,000 characters, indicating a comprehensive report rather than a brief announcement. It includes audited financial data, management statements, and detailed business analysis for the fiscal year 2020. The presence of detailed financial metrics, business operations, and governance information confirms this is the official annual report for the year 2020. Therefore, the document fits the definition of an Annual Report (10-K). FY 2020
2021-04-27 Chinese
2020年度商誉减值测试报告
Audit Report / Information Classification · 95% confidence The document is titled as a '商誉减值测试报告' which translates to 'Goodwill Impairment Test Report' for the fiscal year 2020. It contains detailed financial data including asset group valuations, impairment indicators, goodwill allocation, impairment testing process, assumptions, recoverable amounts, and impairment loss calculations. The document is comprehensive and contains substantive financial analysis and results related to goodwill impairment testing, which is a specific audit-related financial disclosure. It is not a full annual report but a standalone report focused on impairment testing, which aligns with the definition of an Audit Report / Information (AR). The document length (8477 characters) supports it being a full report rather than a brief announcement or certification. Therefore, the appropriate classification is AR (Audit Report / Information). FY 2020
2021-04-27 Chinese
安信证券股份有限公司关于公司2020年度募集资金存放与使用情况的专项核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed report from a sponsoring securities company (安信证券股份有限公司) regarding the 2020 annual special verification opinion on the deposit and use of raised funds by 盈康生命科技股份有限公司. It includes detailed financial figures about the amount raised, usage, balance, management, and cash management of the raised funds. It also contains the auditor's verification opinion and the sponsor's main verification work and conclusion. The document references regulatory rules related to fundraising and securities issuance, and it is a specialized report on the use of raised funds for the year 2020. This type of document is a specialized audit or verification report on fundraising usage, which fits the category of Audit Report / Information (AR) rather than a full Annual Report (10-K) or a simple announcement. The length (5585 characters) and content indicate it is a full report, not just an announcement or certification. Therefore, the correct classification is AR with high confidence. FY 2020
2021-04-27 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.